- Home
- JSPR vs ICCM Comparison
JSPR vs ICCM Comparison
Compare JSPR & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JSPR
- ICCM
- Stock Information
- Founded
- JSPR 2018
- ICCM 2006
- Country
- JSPR United States
- ICCM Israel
- Employees
- JSPR N/A
- ICCM N/A
- Industry
- JSPR Biotechnology: Biological Products (No Diagnostic Substances)
- ICCM
- Sector
- JSPR Health Care
- ICCM
- Exchange
- JSPR Nasdaq
- ICCM Nasdaq
- Market Cap
- JSPR 82.4M
- ICCM 75.8M
- IPO Year
- JSPR N/A
- ICCM N/A
- Fundamental
- Price
- JSPR $5.96
- ICCM $1.41
- Analyst Decision
- JSPR Strong Buy
- ICCM Strong Buy
- Analyst Count
- JSPR 12
- ICCM 2
- Target Price
- JSPR $64.44
- ICCM $2.70
- AVG Volume (30 Days)
- JSPR 452.6K
- ICCM 379.2K
- Earning Date
- JSPR 03-07-2025
- ICCM 04-02-2025
- Dividend Yield
- JSPR N/A
- ICCM N/A
- EPS Growth
- JSPR N/A
- ICCM N/A
- EPS
- JSPR N/A
- ICCM N/A
- Revenue
- JSPR N/A
- ICCM $3,671,000.00
- Revenue This Year
- JSPR N/A
- ICCM $10.03
- Revenue Next Year
- JSPR N/A
- ICCM $62.68
- P/E Ratio
- JSPR N/A
- ICCM N/A
- Revenue Growth
- JSPR N/A
- ICCM 26.02
- 52 Week Low
- JSPR $4.55
- ICCM $0.48
- 52 Week High
- JSPR $31.01
- ICCM $1.66
- Technical
- Relative Strength Index (RSI)
- JSPR 34.64
- ICCM 60.09
- Support Level
- JSPR $4.55
- ICCM $1.22
- Resistance Level
- JSPR $6.55
- ICCM $1.66
- Average True Range (ATR)
- JSPR 0.53
- ICCM 0.09
- MACD
- JSPR 0.49
- ICCM 0.01
- Stochastic Oscillator
- JSPR 56.18
- ICCM 43.18
About JSPR Jasper Therapeutics Inc.
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.
About ICCM IceCure Medical Ltd.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.